Delivery Order SPE2DB24D1104-SPE2DB25FYFJ1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Fluticasone Propionate HFA 44 micrograms in 10.6-gram inhalers, with a ceiling value of $4,633.71. This competitive award, utilizing firm fixed pricing, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9 billion through December 2026. The order is set to be completed by...
- The Defense Logistics Agency awarded a $4,535.86 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fluticasone Propionate HFA 220 MCG inhalers (12 grams). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Fluticasone Propionate HFA 44 mcg 10.6gm inhalers, valued at $1,257.22. This is a firm fixed price delivery order with an ultimate completion date of August 13, 2025, and represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers, valued at $5,930.40. This is a firm fixed price contract with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Fluticasone Propionate HFA 220 MCG 12GM inhalers, valued at $5,454.12. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and requires delivery by August 5, 2025, with performance based in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Fluticasone Propionate HFA 110 MCG inhalers in 12-gram quantities. This competitively awarded, non-set-aside contract has a ceiling value of $1,108.08 with a firm fixed price and an ultimate completion date of August 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the primary contractor for this delivery order under its...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers. This is a firm fixed-price, non-set-aside contract with a ceiling value of $1,051.91 and an ultimate completion date of August 15, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,715.83 on July 29, 2025, for the supply of Fluticasone Propionate HFA 44 microgram inhalers (10.6 grams). This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. The product will be...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,948.50 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Fluticasone Propionate HFA 220 MCG inhalers (12 GM units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the vendor's existing Indefinite Delivery Contract with DLA Troop Support Medical. The order is scheduled for completion by July 29, 2025, with performance based at the...
- The Defense Logistics Agency awarded a $4,577.52 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for Fluticasone Propionate HFA 220 MCG inhalers (12 grams). This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with completion targeted for July 25,...
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB25FYFJ1Delivery Order
On September 4, 2025, the Defense Logistics Agency awarded a delivery order contract valued at $8,680.24 to AmerisourceBergen Drug Corp for the supply of Fluticasone Propionate HFA 220 microgram 12-gram inhalers. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 5, 2025. The contract will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. The parent IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines. The Defense Logistics Agency's Medical Supply Chain utilizes this flexible contract vehicle to fulfill pharmaceutical needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.